Forecasting The Impact Of Climate Change On Dengue Transmission
Funder
National Health and Medical Research Council
Funding Amount
$506,432.00
Summary
Dengue fever (DF) is the most important mosquito-transmitted viral disease in the world. The large-scale re-emergence of DF in the Asia-Pacific region during the past few decades has renewed its status as a serious international public health problem. Global climate change is anticipated to impact upon the biology and ecology of vectors and consequently the risk of DF transmission. The principal research aim of this study is to project the impact of future climate change on DF.
Spatiotemporal Risk Assessment Of Emerging Infectious Disease Threats To Australia
Funder
National Health and Medical Research Council
Funding Amount
$641,204.00
Summary
Emerging infectious diseases (EIDs) such as dengue and influenza pose a constant and growing threat to Australians. We live in an increasingly connected world in which EIDs cross borders and oceans, carried by infected people or vectors. This research will build an evidence base for allocation of resources to surveillance and preventive health programmes aimed at mitigating the threat of EIDs, through identifying high-risk sources, routes of introduction, incursion locations and communities.
Dengue Transmission Under Climate Change In Northern Australia: Linking Ecological And Population Based Models To Develop Adaptive Strategies
Funder
National Health and Medical Research Council
Funding Amount
$444,293.00
Summary
The mosquito-transmitted viral disease, dengue, is likely to be influenced by climate change. It has been accorded priority for human health adaptation research (National Adaptation Research Plan, Human Health). Dengue has major health impacts in North Queensland, and causes major losses to the Queensland blood supply. The research will develop a model for climate-related changes in the future occurrence of dengue to predict risk in North Queensland and other parts of Australia.
Risk Factors For Long-term Chronic Disease Events In HIV-positive Persons: The D:A:D Cohort Study
Funder
National Health and Medical Research Council
Funding Amount
$925,659.00
Summary
The D:A:D Study is a large, international study assessing risk factors for chronic disease events in HIV-positive patients. We know these events, such as heart attacks and cancers, increase with age. And we also know that these events are more common in HIV-positive people. Over the next five years, D:A:D will assess risk factors for chronic disease events in HIV-positive people as they age, and help optimise patient monitoring and management.
Enterovirus, Vitamin D Status And Inflammation At The Clinical Onset Of Type 1 Diabetes In Childhood
Funder
National Health and Medical Research Council
Funding Amount
$410,542.00
Summary
Type 1 diabetes is a serious disease that is increasing in incidence among Australian children. This project will build on an exsisting study to provide new information on the role of enteroviral infection, vitamin D status and the associated inflammatory changes in blood at the onset of disease.
HIV Pre-exposure Prophylaxis In Men Who Have Sex With Men: Investigating Impacts On HIV Incidence And Novel Methods Of Engagement
Funder
National Health and Medical Research Council
Funding Amount
$318,768.00
Summary
HIV infections are increasing in gay men and other men who have sex with men (MSM) in Australia and Indonesia. A promising new HIV prevention strategy is HIV pre-exposure prophylaxis (PrEP), which involves HIV-negative individuals taking one pill containing HIV treatments per day to prevent infection. PrEP is highly effective when taken correctly. Access to PrEP is currently very limited. Studies to investigate the best ways to implement PrEP services are required in Australia and Indonesia.
HIV Treatment As Prevention: A Longitudinal Assessment Of Population Effectiveness
Funder
National Health and Medical Research Council
Funding Amount
$783,160.00
Summary
This project is a large-scale evaluation of an HIV strategy known as ‘treatment as prevention’ (TasP). Through routine and repeat HIV testing for gay men and early treatment initiation following diagnosis, TasP aims to reduce HIV community infection rates. Through the establishment of a large cohort of gay men in NSW and Victoria, this study will track HIV testing, treatment and management to assess the real-world efficacy of TasP for reducing HIV infections among this at-risk population.
People With HIV Still Die Young – Preventing Non-AIDS-associated Comorbidity
Funder
National Health and Medical Research Council
Funding Amount
$408,768.00
Summary
There are over 36 million people in the world infected with HIV. While people with HIV can now live an almost normal life through the use of medication, they have a very high risk of heart problems, cancer and other common illnesses. It is important to find ways of reducing the cost of treating these common illnesses and to make sure that people with HIV can live a long, happy life. This project aims to find the best ways to stop people with HIV getting heart trouble or dying from liver cancer.